Health GAP Press Statement
www.globaltreatmentaccess.org | www.healthgap.org

(Evian) At the opening of the G8 Summit in Evian, AIDS activists decried the refusal of the G7 donors to fulfill their promise to fund the Global Fund to fight AIDS, Tuberculosis and Malaria (Global Fund). The Global Fund was launched by the G8 during the Genoa Summit in 2001. "With an epidemic expected to explode from 42 million in 2003 to 100 million infected people by 2010, the agreement by Bush, Chirac, Blair and Schršder to abandon the Global Fund is a shameful and dangerous betrayal of past promises," said Asia Russell of Health GAP. According to activists, because donor countries have avoided paying their fair share to Global Fund, it will be bankrupt before its third round of grants, scheduled for October 2003 and expected to cost $1.6 billion.

"The Heads of State who created this Fund pumped it for positive publicity two years ago, and now have decided to orphan it, after deliberately manipulating the hopes and expectations of millions of people with HIV in developing countries," said Sharonann Lynch of Health GAP. The Global Fund is a multilateral financing mechanism that so far has committed $1.5 billion of funding for 93 programs in developing countries. Experts consider the Global Fund currently the best hope for scaling up life extending HIV treatment access in developing countries.

The unspent 10 billion euros in the European Development Fund (EDF) is further indication of the indifference of wealthy countries to the fate of the Global Fund, and to the fate of people living with HIV, say activists. "8500 people with AIDS die each day because they don't have the resources the Global Fund can help provide. People with AIDS have no time to wait for the EDF to decide whether it can free up 10 billion euros to fund the Global FundÑrapid, streamlined disbursement of this money is crucial," said Kris Hermes of Health GAP.

Even President Bush's much-lauded 5-year plan to spend $10 billion in new money on AIDS in 14 African and Caribbean countries is hobbled by his stingyÑand dwindlingÑcontribution to the new Global Fund, according to activists. "The Global Fund is up and running now, unlike Bush's untested bilateral program," said Sharonann Lynch of Health GAP. "The Global Fund's efforts building infrastructure, strengthening procurement networks, and developing treatment literacy among people with HIV provide a foundation that the Bush plan needs in order to have any hope of success. But without money, the Global Fund can't succeed."

In addition to quashing increased contributions to the Global Fund, for more than one year the White House has single handedly blocked efforts at the WTO to secure broader access to exported generic medicines for poor countries with inefficient capacity for local production of medicines. A leaked copy of U.S. comments to the draft G8 Health Communique shows the U.S. will avoid any mention of key issues impeding access to medicines, including drug pricing and the impact intellectual property on medicines access. "The issue of access to affordable generic medicines is the litmus test for whether or not global trade rules benefit the world's poor," said Brook Baker of Health GAP. "The White House's intransigence on this issue is just one more example of its willingness to ignore international commitments and jeopardize access to desperately needed medicines."

New contributions to the Global Fund will be announced during the Summit, but are likely to be insignificant. "The UK announced this week they would extend their miserly contribution of $40 million annually out two more years to 2007 and 2008," said Amanda Lugg of Health GAP. "The Global Fund's cash crunch of $1.4 billion is happening nowÑmaking the sham British commitment about as helpful as trying to patch the Titanic with a Band-Aid."

HEALTH GAP DEMANDS G7 DONORS:

Support regular funding for the Global Fund to fight AIDS, Tuberculosis, and Malaria, calculated as a proportion of a country's overall wealth;

Act now to close the Global Fund's $1.4 billion funding gap for 2003;

Commit unspent EDF money to funding the Global Fund;

Commit to Global Fund financing based on the Fund's projections of need, accounting for periodic adjustment;

Support a solution to the problem of access to exported generic medicines in poor countries with inefficient manufacturing capacity that is straightforward, economically viable, and puts the public health interests of poor countries before the commercial interests of multinational pharmaceutical companies.